Gold Mini Futures (MCX) (MMI)

Marcus & Millichap (NYSE:MMI) Stock, Quote.Headers.trade-ideas

Marcus & Millichap

Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Equities

News

Small Cap

Markets

General

Real estate brokerage firm Marcus &amp; Millichap Inc (NYSE: MMI) has signed a strategic partnership, including an equity investment and commercial relationship with Archer, a venture-backed real estate technology company. The financial details were not disclosed.

Marcus &amp; Millichap Invests In Real Estate Technology Company Archer - What&#39;s On The Cards?

Penny Stocks

Intraday Update

Movers

Trading Ideas

ALTI

ASPN

BAER

DCOM

GNLX

INTC

NTCT

TOUR

VEON

WISA

WRLD

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Friday. Here are some big stocks recording losses in today’s session.

Intel, Hasbro, Colgate-Palmolive And Other Big Stocks Moving Lower On Friday

Real Estate

Whether you call it a log jam or gridlock, several advisers and trade media are heralding a split U.S. Congress as good news for corporate America. 

A Split Congress May Be Good News For Commercial Real Estate Investors

Marcus & Millichap Inc

Metro Mining Ltd

NYLI MacKay Muni Insured ETF

MARMION INDUS CORP by Marmion Industries Corp.

Marmion Industries Corp

MedMira Inc

NYLI MacKay Muni Intermediate ETF

Reported Earlier, Marcus & Millichap Closes $187.5M Deal For 497-Unit Multifamily Phoenix Property

<p>Wells Fargo  analyst Blaine Heck   maintains Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) with a Underweight and raises the price target from $20 to $30.</p>


Price Target

Analyst Ratings

Wells Fargo Maintains Underweight on Marcus & Millichap, Raises Price Target to $30

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 39.13 percent increase over losses of $(0.23) per share from the same period last year.  The company reported quarterly sales of $158.37 million which missed the analyst consensus estimate of $160.70 million by 1.45 percent.  This is a 2.76 percent decrease over sales of $162.87 million the same period last year.</p>


Earnings

Earnings Beats

Earnings Misses

Marcus & Millichap Q2 GAAP EPS $(0.14) Beats $(0.15) Estimate, Sales $158.37M Miss $160.70M Estimate

<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.institutionalpropertyadvisors.com%2F&amp;esheet=54038247&amp;newsitemid=20240606951680&amp;lan=en-US&amp;anchor=IPA+Capital+Markets&amp;index=1&amp;md5=2b133f780cc6d88da52ea366abc39c1f">IPA Capital Markets</a>, a division of&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.marcusmillichap.com%2F&amp;esheet=54038247&amp;newsitemid=20240606951680&amp;lan=en-US&amp;anchor=Marcus+%26amp%3B+Millichap+%28NYSE%3AMMI%29&amp;index=2&amp;md5=b2e5c71653f52015d1fe3dd5fc153f21">Marcus &amp; Millichap (NYSE:</a><a href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), specializing in capital markets services for major private and institutional clients, announced the&nbsp;$72.24 million&nbsp;refinance of La Vista City Centre, a growing master-planned multifamily, office and retail development in La Vista, Nebraska.</p>
<p>Frank Montalto, IPA Capital Markets managing director based in the firm&#39;s Chicago office, secured the financing on behalf of City+Ventures, a Nebraska-based investment and development company that partnered with the City of La Vista beginning in 2015 for the development of the community.</p>


Reported Earlier, Marcus & Millichap's IPA Division Secures $72M For Refinancing Omaha's La Vista City Centre

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 73.33 percent decrease over losses of $(0.15) per share from the same period last year.  The company reported quarterly sales of $129.10 million which beat the analyst consensus estimate of $127.50 million by 1.26 percent.  This is a 16.60 percent decrease over sales of $154.79 million the same period last year.</p>


Marcus & Millichap Q1 GAAP EPS $(0.26) Beats $(0.28) Estimate, Sales $129.10M Beat $127.50M Estimate

<p>Institutional Property Advisors (IPA), a division of Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), announced today the sale and financing of Alta Chandler at The Park, a 291-unit mid-rise multifamily asset in Chandler, Arizona. The property traded for&nbsp;$94.5 million, which represents&nbsp;$324,742&nbsp;per unit. IPA Capital Markets arranged&nbsp;$52 million&nbsp;in acquisition financing.</p>


Reported Earlier, Marcus & Millichap's Institutional Property Advisors Brokers Sale And Arranges Financing For $94.5M Southeast Phoenix Multifamily Asset

<p>The company said, notwithstanding the ongoing price discovery and wider than normal bid/ask spreads, the commercial real estate transaction market is poised over the long-term to overcome the near term challenges which are currently expected to extend for the first half of 2024.</p>


Guidance

Marcus & Millichap Says It Remains Well-positioned To Achieve Long-term Growth

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 235 percent decrease over earnings of $0.20 per share from the same period last year.  The company reported quarterly sales of $166.24 million which missed the analyst consensus estimate of $171.20 million by 2.90 percent.  This is a 36.66 percent decrease over sales of $262.45 million the same period last year.</p>


Marcus & Millichap Q4 EPS $(0.27) Beats $(0.28) Estimate, Sales $166.24M Miss $171.20M Estimate

<p><strong>Marcus &amp; Millichap</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is set to give its latest quarterly earnings report on Friday, 2024-02-16. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Marcus &amp; Millichap will report an <strong>earnings per share</strong> (EPS) of $-0.28. </p>
<p>Marcus &amp; Millichap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Marcus &amp; Millichap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2023</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.26</td>
<td>-0.23</td>
<td>-0.17</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.24</td>
<td>-0.23</td>
<td>-0.15</td>
<td>0.20</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.01%</td>
<td>-1.53%</td>
<td>1.69%</td>
<td>1.59%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1708009233_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Marcus &amp; Millichap were trading at $38.61 as of February 14. Over the last 52-week period, shares are up 12.51%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MMI/earnings"><strong>To track all earnings releases for Marcus &amp; Millichap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Marcus & Millichap Earnings Preview

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Alta Cooley Station, a 248-unit, mid-rise multifamily property in Cooley Station, an upscale master-planned community in Gilbert, Arizona. The asset traded for&nbsp;$80 million, which equates to&nbsp;$322,581&nbsp;per uni</p>


Marcus & Millichap's Institutional Property Advisors Closed A $80M Multifamily Asset Sale In Gilbert, Arizona

Reported Earlier, Marcus & Millichap Enters Strategic Partnership With EquityMultiple

Marcus & Millichap Enters Strategic Partnership That Includes An Equity Investment And Commercial Relationship With Real Estate Technology Firm Archer

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 145.28 percent decrease over earnings of $0.53 per share from the same period last year.  The company reported quarterly sales of $162.03 million which missed the analyst consensus estimate of $164.80 million by 1.68 percent.  This is a 49.97 percent decrease over sales of $323.84 million the same period last year.</p>


Marcus & Millichap Q3 EPS $(0.24) Beats $(0.26) Estimate, Sales $162.03M Miss $164.80M Estimate

<p><strong>Marcus &amp; Millichap</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is set to give its latest quarterly earnings report on Friday, 2023-11-03. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Marcus &amp; Millichap will report an <strong>earnings per share</strong> (EPS) of $-0.26. </p>
<p>Marcus &amp; Millichap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.00, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Marcus &amp; Millichap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
<th><strong>Q3 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.23</td>
<td>-0.17</td>
<td>0.19</td>
<td>0.55</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.23</td>
<td>-0.15</td>
<td>0.20</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.53%</td>
<td>1.69%</td>
<td>1.59%</td>
<td>0.38%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2023/1698940925_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Marcus &amp; Millichap were trading at $29.22 as of November 01. Over the last 52-week period, shares are down 13.9%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MMI/earnings"><strong>To track all earnings releases for Marcus &amp; Millichap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: Marcus & Millichap

Marcus & Millichap's Institutional Property Advisors Closed A $106.65M Multifamily Asset Sale In California's San Fernando Valley

Marcus & Millichap's Military Bridge To Brokerage Spearheads Legislation To Help Veterans

<p><a href="https://www.marcusmillichap.com/news-events/press/2023/10/10-19-fairfield-inn-salem">https://www.marcusmillichap.com/news-events/press/2023/10/10-19-fairfield-inn-salem</a></p>
<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of a Fairfield Inn &amp; Suites located in Salem, Virginia. The property sold for an undisclosed price.<br /><br />Chase Dewese, Jack Davis and Joce Messinger, investment specialists with the DDM Hotel Group of Marcus &amp; Millichap, procured the buyer on behalf of the developer, Kaylan Hospitality. Brian Hosey assisted in the transaction as Virginia broker of record.<br /><br />"We were able to engage an out-of-state buyer looking to expand his asset portfolio in the western Virginia market," says Dewese. "Kaylan Hospitality, one of the well-known developers in the region, delivered an exceptional product."<br /><br />"Our team continues to perform and uncover value in the southeast, even during this period of economic uncertainty," adds Davis.&nbsp;<br /><br />The hotel is located at 121 Sheraton Drive in Salem. Featuring 113 guest rooms, it was built on 3.13 acres in 2017.&nbsp;</p>


Asset Sales

Marcus & Millichap Inc Announces Sale Of Fairfield Inn & Suites In Salem; No Financial Terms Disclosed

<p>Waters Edge, a 304-unit multifamily asset located in The Lakes master-planned community, consisting of high-end waterfront single-family residences, condos, and apartments in Kent, Washington. The property sold for&nbsp;$80 million, or&nbsp;$263,125&nbsp;per unit.</p>


Marcus & Millicha's Institutional Property Advisors Brokers $80M Puget Sound Multifamily Asset Sale

Marcus & Millichap Division IPA Reports Sale Of Aiya, A 360-Unit Multifamily Asset In Gilbert, Arizona For $112M, Or $311,111 Per Unit

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 122.12 percent decrease over earnings of $1.04 per share from the same period last year.  The company reported quarterly sales of $162.87 million which beat the analyst consensus estimate of $151.50 million by 7.50 percent.  This is a 58.87 percent decrease over sales of $395.96 million the same period last year.</p>


Marcus & Millichap Q2 EPS $(0.23), Inline, Sales $162.87M Beat $151.50M Estimate

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The stock market can be a wild rollercoaster ride. Not everyone has the stomach for all the ups and downs in the market. Hard-earned cash can get burned through novice mistakes, market surprises, or other events. As a result, some investors are on the lookout for stocks to sell.</p>



<p>Many investment advisors and brokerages offer research and recommendations to help investors decide which stocks their customers should buy or cut out of their portfolios. But if you&rsquo;re looking for more, I&rsquo;ll look at three stocks with failing marks on Wall Street today. To screen for my list, I used the criteria below.&nbsp;</p>



<ul><li>Stocks with sell recommendations from analysts</li>



<li>Companies with a decline in the latest reported annual earnings</li>



<li>A decline in the latest reported annual revenue</li>
</ul><p>Then, I arranged the top three stocks from lowest to highest <em>net income decrease</em>. Here are the results:&nbsp;</p>



<h2>Zim Integrated Shipping Services (ZIM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/zim_shipping1600-2-300x169.png" alt="A large ULCV container ship underway, sails on open water fully loaded with containers and cargo - the ZIM San Francisco"><div>Source: ImagineStock / Shutterstock.com</div></div><p><strong>Zim Integrated Shipping Services</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/zim-stock-quote/"><strong>ZIM</strong></a>) is one of the top 20 global container liner shipping carriers and operates a fleet and network of shipping lines specializing in cargo handling and transportation services.&nbsp;</p>



<p>Its global network operates in <a href="https://www.zim.com/global-network">Africa, the Americas, Europe, Asia, and Oceania</a>. The company is undergoing a fleet renewal program to revamp its fleet and transition to a fuel-efficient modern containership.</p>



<p>According to its latest financials, Zim Integrated suffered a significant setback in 2023. Revenue fell by a <a href="https://investors.zim.com/files/doc_financials/2023/q4/zim-q4-2023-earnings-release-eng-final-13-3-2024-with-logo-accessible.pdf">whopping 59% YOY</a>, ending at $5.16 billion compared to $12.56 billion in 2022. Scrutinizing the report further leads to several other harrowing metrics.&nbsp;</p>



<p>Adjusted EBITDA fell 86%, the average freight rate per twenty-foot equivalent unit (TEU) decreased by 63%, and the company&rsquo;s net leverage ratio (a measure of its ability to meet its financial obligations) was 2.2x. For reference, the typical low-risk net leverage ratio is closer to 1.0.&nbsp;</p>



<p>Finally, the company&rsquo;s net loss hit $2.69 billion, starkly contrasting 2022&rsquo;s $4.63 billion profit.&nbsp;</p>



<p>President and CEO Eli Glickman&rsquo;s statement in the report was also quite telling. He said, &ldquo;Looking ahead, we intend to continue to take decisive steps to further benefit from our strategic transformation and expect ZIM to emerge in a stronger position than ever in <em>2025 and beyond</em>.&rdquo;&nbsp;</p>



<p>Read between the lines: Glickman&rsquo;s statement says 2024 will <em>not</em> be Zim Integrated&rsquo;s turnaround year. No wonder analysts rate ZIM <a href="https://www.nasdaq.com/market-activity/stocks/zim/analyst-research">stock as a hold</a>, though some sources rate it as a sell. </p>



<h2>NL Industries (NL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/03/stock-market-down1600-300x169.png" alt="Stock crash market exchange loss trading graph analysis investment indicator business graph charts of financial digital background down stock crisis red price in down trend chart fall. Why are stocks down today?"><div>Source: Bigc Studio / Shutterstock.com</div></div><p><strong>NL Industries</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/nl-stock-quote/"><strong>NL</strong></a>) is a holdings company that owns CompX. CompX specializes in locking mechanisms for transportation, furniture, and other applications. Through its marine components operations, the company also produces stainless steel exhaust systems, throttle controls, and related hardware. NL Industries also owns a minority non-controlling interest in titanium dioxide pigments producer and marketer Kronos Worldwide.</p>



<p>The company reported a slight decline in revenue for FY&rsquo;23, ending the year at <a href="https://nlindustries.gcs-web.com/news-releases/news-release-details/nl-reports-fourth-quarter-2023-results">$161.3 million compared to 2022&rsquo;s $166.6 million</a>. While that might not sound so bad, the real bad news can be found further down their report.&nbsp;</p>



<p>Net loss was $2.3 million, a 106.8% decrease from 2022&rsquo;s $33.8 million profit. The report also showed a $15 million loss from Kronos Worldwide, potentially signifying unsustainable demand fluctuations. As a result, <strong>Barclays</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/bcs-stock-quote/"><strong>BCS</strong></a>) recommends <a href="https://www.nasdaq.com/market-activity/stocks/nl/analyst-research">selling NL stock</a>.&nbsp;</p>



<h2>Marcus &amp; Millichap (MMI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/real-estate-closing-contract-300x169.png" alt="An image of two people with a housing contract, hands holding a pen, hands holding a calculator with a house in the background"><div>Source: 89stocker / Shutterstock</div></div><p>Marcus &amp; Millichap (NYSE:<a href="https://investorplace.com/stock-quotes/mmi-stock-quote/"><strong>MMI</strong></a>) is a real estate investment, financing, research, and advisory firm in the US and Canada. The company has been operating for over 50 years and offers property search functions, market research, real estate news, and more. It also operates a 1031 exchange for accredited real estate investors.&nbsp;</p>



<p>Like the two others on this list of stocks to sell, 2023 was not a good year for Marcus &amp; Millichap, as its top line fell by <a href="https://ir.marcusmillichap.com/news-events/press-releases/detail/342/marcus-millichap-inc-reports-results-for-fourth-quarter">$655.8 million or 50.4% YOY</a>. Despite lowering operating expenses and services costs by 39.4% and 63.0%, the company ended the year with a $34 million loss. That&rsquo;s a 132.63% decrease compared to 2022&rsquo;s $104.2 million net income. Yikes.&nbsp;</p>



<p>While the company is confident it is poised to &ldquo;overcome the near-term challenges,&rdquo; analysts at <strong>Wells Fargo</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/wfc-stock-quote/"><strong>WFC</strong></a>) don&rsquo;t share the same sentiment. The analyst firm gives MMI stock a <a href="https://www.nasdaq.com/market-activity/stocks/mmi/analyst-research">Sell recommendation</a>, earning it the final spot in this edition of my &ldquo;stocks to sell&rdquo; list.&nbsp;</p>



<p><em>On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a>.</p>
<div><p>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/3-stocks-to-dump-before-the-market-goes-bust/">3 Stocks to Dump Before the Market Goes Bust</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Stocks to Dump Before the Market Goes Bust

Wells Fargo analyst Blaine Heck maintained a Sell rating on Marcus & Millichap (MMI – Research Report) today and set a price target of $20.00. Blai...

Persistent Real Estate Weakness Spurs Sell Rating for Marcus & Millichap

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The end of the pandemic served as a springboard for the economy, launching us into a new bull market. I can&rsquo;t blame people for being optimistic after seeing the meteoric rise of several big-name stocks. AI continues to dominate tech, carrying the rest of the sectors. As a direct result, the <a href="https://www.cnbc.com/2024/07/09/stock-market-today-live-updates.html"><strong>S&amp;P 500</strong> closed above $5,600 for the first time</a>. So that&rsquo;s the good news. However, even in this market condition, savvy investors should be on the lookout for stocks to sell now.</p>



<p>This brings us to the bad news. Unfortunately, bull markets can&rsquo;t do much for companies already struggling to keep their heads above the water. Warning signs include deteriorating financial conditions, unflattering Wall Street ratings and bleak prospects. All these point to a downward spiral, and prudent investors might want to jump ship to keep their portfolios intact.&nbsp;</p>



<p>To come up the list of stocks to sell now, I screened for the following criteria:&nbsp;</p>



<ul><li>Must have a sell, underperform or strong sell rating from analysts,</li>



<li>Negative YOY revenue growth on its latest annual report,</li>



<li>Negative YOY earnings growth on its latest annual report.</li>
</ul><p>Then, I arranged the stocks from highest to lowest revenue percentage loss. Here are the results:</p>



<h2>Marcus &amp; Millichap (MMI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/real-estate-stocks-keys-city-1600-300x169.jpg" alt="hand of person in a suit dangling keys with a house symbol on the ring. Windows overlooking city skyline in background."><div>Source: ImageFlow/shutterstock.com</div></div><p><strong>Marcus &amp; Millichap</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mmi-stock-quote/"><strong>MMI</strong></a></span>) is a brokerage firm specializing in commercial real estate sales, research, advisory and financing services.<strong> </strong>It operates in four main commercial real estate business segments:</p>



<ul><li>Properties&nbsp;</li>



<li>Middle market</li>



<li>Private client market</li>



<li>Larger transaction market.</li>
</ul><p>The company serves its clients with different types of property portfolios that match their needs, helping to maximize their value while securing competitive financing from lenders. Marcus &amp; Millichap also caters to the private market through its investment brokerage and financing.&nbsp;</p>



<p>Marcus &amp; Millichap had a rough 2023. <a href="https://ir.marcusmillichap.com/news-events/press-releases/detail/342/marcus-millichap-inc-reports-results-for-fourth-quarter">President and CEO Hessam Nadji</a> states that the &ldquo;ongoing market disruption created by the Fed&rsquo;s fight against inflation and persistent interest rate volatility impacting real estate valuations&rdquo; negatively impacts the company&rsquo;s performance.&nbsp;</p>



<p>So, let&rsquo;s get into the gory details. FY 2023&rsquo;s revenue is down a full 50.4% YOY, reflected evenly across all its revenue sources. The year ended with a $0.88 net loss per share, compared to FY 2022&rsquo;s $2.59 profit.&nbsp;</p>



<p>Nadji states that the company is focused on maintaining a strong balance sheet and improving client relations. However, analysts aren&rsquo;t impressed with the news; MMI stock currently <a href="https://www.nasdaq.com/market-activity/stocks/mmi/analyst-research">has a sell rating</a>, which might be a good enough reason to tack MMI on your list of stocks to sell now.&nbsp;</p>



<h2>Medifast (MED)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-300x169.jpg" alt="Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy"><div>Source: metamorworks / Shutterstock</div></div><p>Known for being the parent company of OPTAVIA, one of the fastest-growing health and wellness communities, <strong>Medifast </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/med-stock-quote/"><strong>MED</strong></a></span>) provides a comprehensive approach to achieving lasting optimal health and well-being through clinically proven health benefits and evidence-based tools. These tools include a habit-creation framework guided by its independent coaches and supportive community.</p>



<p>The company also provides access to board-certified affiliated clinicians and medications that help treat obesity and other health conditions.</p>



<p>Medifast&rsquo;s FY 2023 report painted quite a bleak picture for the company. Revenue is down 32.9% YOY to $1.1 billion. The bottom line is no better, dropping from $12.73 per diluted share in FY 2022 to $9.10. Even on a non-GAAP basis, EPS is still 33.5% lower YOY.&nbsp;</p>



<p>&ldquo;We are realigning our business to respond to the evolving dynamics of the weight loss industry and to aggressively execute on bold initiatives to transform our business model,&rdquo; said <a href="https://ir.medifastinc.com/2024-02-20-Medifast-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results">Chairman and CEO Dan Chard</a>.&nbsp;</p>



<p>Analysts maintain MED stock an &ldquo;<a href="https://www.nasdaq.com/market-activity/stocks/med/analyst-research">underperform</a>&rdquo; rating until things turn around. So when exactly is that?&nbsp;</p>



<p>&ldquo;This remains a challenging market,&rdquo; says Chard, &ldquo;and it will take time to navigate the transformational path that we are on.&rdquo;</p>



<p>In the meantime, investors holding onto Medifast stock might want to sell the stock and shop around for better prospects.</p>



<h2>Worthington Enterprises (WOR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/manufacturing-1600-300x169.jpg" alt="Male and Female Industrial Engineers in Hard Hats Discuss New Project while Using Laptop. They Make Showing Gestures.They Work in a Heavy Industry Manufacturing Factory. manufacturing stocks"><div>Source: Gorodenkoff via Shutterstock</div></div><p><strong>Worthington Enterprises</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/wor-stock-quote/"><strong>WOR</strong></a></span>) is a diversified manufacturing company that operates into two main business segments:</p>



<ul><li><strong>Consumer products</strong>: tools, celebrations and outdoor living products.</li>



<li><strong>Building products</strong>: heating, water and cooling solutions.</li>
</ul><p>Worthington Enterprises is known for its focus on providing value-added steel processing and manufacturing. The company&rsquo;s product brand portfolio includes Coleman, Garden-Weasel, PowerCore and HALO. It also operates in lightweight, customizable LPG composite cylinders.&nbsp;</p>



<p>Worthington recently announced its FY 2024 results &mdash; and, in case you hadn&rsquo;t guessed, it&rsquo;s not pretty. Net sales dropped from $1.42 billion to $1.25 billion, a 12% decrease. While expenses were down for the year, the report still recorded a <a href="https://ir.worthingtonenterprises.com/news/news-details/2024/Worthington-Enterprises-Reports-Fourth-Quarter-Fiscal-2024-Results/default.aspx">$73.5 million operating loss</a>.&nbsp;</p>



<p>The company <em>was</em> profitable in FY 2024, but diluted EPS decreased from $5.19 to $2.20. While management is cautiously optimistic, analysts still rate WOR stock an &ldquo;<a href="https://www.nasdaq.com/market-activity/stocks/wor/analyst-research">underperform</a>.&rdquo; If you&rsquo;re holding on to the company, maybe it&rsquo;s time to consider WOR as an option in stocks to sell.&nbsp;</p>



<p><em>On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a>.</p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/time-to-unload-3-stocks-in-deep-trouble-to-sell-now/">Time to Unload: 3 Stocks in Deep Trouble to Sell Now</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Time to Unload: 3 Stocks in Deep Trouble to Sell Now

Marcus & Millichap declares $0.25 dividend

Institutional Property Advisors announces sale of Marlowe Grapevine property

Marcus &amp; Millichap GAAP EPS of -$0.14, revenue of $158.37M

Marcus & Millichap, Inc. 2024 Q2 - Results - Earnings Call Presentation

Marcus & Millichap, Inc. (MMI) Q2 2024 Earnings Call Transcript

Analyst Blaine Heck of Wells Fargo maintained a Sell rating on Marcus & Millichap (MMI – Research Report), retaining the price target of $20.00. Bl...

Sell Rating on Marcus & Millichap Amidst Market Volatility and Financial Uncertainties

In a report released today, Ike Boruchow from Wells Fargo maintained a Sell rating on Marcus & Millichap (MMI – Research Report), with a price targ...

Wells Fargo Sticks to Their Sell Rating for Marcus & Millichap (MMI)

Press Releases

Marcus & Millichap's IPA Capital Markets Division Arranges $85 Million Financing for New York City Industrial Condominium

Marcus & Millichap Declares Regular Semi-Annual Dividend of $0.25 Per Share

Institutional Property Advisors Brokers Multifamily Asset Sale in Suburban Dallas-Fort Worth

Marcus & Millichap, Inc. Reports Results for Second Quarter 2024

Marcus & Millichap's Institutional Property Advisors Closes $87 Million Mixed-Use Asset Sale in California's San Gabriel Valley

Marcus & Millichap's Institutional Property Advisors Brokers $95 Million Multifamily Sale in Greater Los Angeles

Marcus & Millichap's IPA Capital Markets Announces Strategic Hire of Industry Veteran in Dallas

Marcus & Millichap's Institutional Property Advisors Closes $187.5 Million Multifamily Asset Sale in Phoenix

Marcus & Millichap Brokers Record-Breaking Manufactured Housing Asset Sale in Malibu

Marcus & Millichap's IPA Capital Markets Arranges $75 Million Financing for Midtown Manhattan Office-to-Residential Conversion Project

Altisource Portfolio Solutions S.A. - Common Stock

Altisource Portfolio

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Marcus & Millichap

Marcus & Millichap (MMI) Forecast

Marcus & Millichap (NYSE:MMI) Stock, Quote.Headers.trade-ideas